Selecting Optimal First-line Antiretroviral Therapy for Rapid Start

Gain expert perspectives on the available safety and efficacy data on recommended regimens for rapid start in newly diagnosed patients with HIV.

Share

Program Content

Activities

Slides: Rapid Start Options
Safety and Efficacy of Recommended Regimens for Rapid Initiation of First-line ART
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: March 25, 2020

Expires: March 24, 2021

Activities

Rapid ART: What to Start
Rapid ART: How I Select Among Recommended Regimens
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: April 17, 2020

Expires: April 16, 2021

Faculty

cover img faculity

Monica Gandhi, MD, MPH

Professor of Medicine
Associate Chief, Division of HIV, Infectious Diseases and Global Medicine
Director, Center for AIDS Research
Medical Director, Ward 86 HIV Clinic
University of California, San Francisco 
San Francisco, California

cover img faculity

Gregory Huhn, MD, MPHTM

Interim Chief, Division of Infectious Diseases
Senior Director of HIV Services
Cook County HIV Integrated Programs
Interim Medical Director, The RMR CORE Center
Professor, Division of Infectious Diseases
Rush University Medical Center
Chicago, Illinois

Provided by

ProCE Banner

Supporters

Supported by an educational grant from

Janssen Therapeutics Division of Janssen Products